Immunome IMNM
NASDAQ IMNM
$20.90 +0.01 (+0.05%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunome (IMNM) Return on Assets [ROA] (2020 - 2026)

Updated

Immunome's Return on Assets [ROA] came in at -45.64% for Q2 2026, up 24.66 percentage points from -70.30% a year earlier but down 8.99 percentage points from the prior quarter.

Analysis

Immunome (IMNM) Return on Assets [ROA] (2020 - 2026) Analysis & Trends

For FY2025, Immunome's Return on Assets [ROA] was -48.54%, up 108.77 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of +0.92 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Assets [ROA] was -157.31% in FY2024 (-30.38 pp), -126.93% in FY2023 (-36.89 pp), -90.03% in FY2022 (-40.83 pp) and -49.20% in FY2021 (+0.25 pp).
  • The five-year range for quarterly Return on Assets [ROA] is -135.19% (Q4 2022) to -33.68% (Q3 2023).
  • Year-over-year, Return on Assets [ROA] has increased for six consecutive quarters, with an average year-over-year change of +13.41 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in Q4 2025 (a gain of 77.41 percentage points), and the weakest in Q4 2022 (a drop of 93.35 percentage points).
  • Business Quant data shows IMNM's Return on Assets [ROA] at -36.66% (Q1 2026), -45.62% (Q4 2025) and -78.64% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Immunome 2.37 Bn 341.22 Mn - -45.64%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -45.64%
Mar 31, 2026 -36.66%
Dec 31, 2025 -45.62%
Sep 30, 2025 -78.64%
Jun 30, 2025 -70.30%
Mar 31, 2025 -74.84%
Dec 31, 2024 -123.02%
Sep 30, 2024 -114.80%
Jun 30, 2024 -88.18%
Mar 31, 2024 -101.37%
Dec 31, 2023 -90.63%
Sep 30, 2023 -33.68%
Jun 30, 2023 -59.33%
Mar 31, 2023 -82.37%
Dec 31, 2022 -135.19%
Sep 30, 2022 -106.25%
Jun 30, 2022 -83.34%
Mar 31, 2022 -62.39%
Dec 31, 2021 -41.84%
Sep 30, 2021 -33.83%
API Access

Immunome Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IMNM&period=max&api_key=YOUR_API_KEY